{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:52:57Z","timestamp":1785909177212,"version":"3.56.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Type 2 diabetes (T2D) is a significant metabolic disorder with disproportionately high burden in obese South Asian populations, yet not all obese individuals develop the disease. This study identified the metabolic, inflammatory, and pharmacological markers associated with prevalent T2D in obese Indians using age- and sex-matched case-control analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A matched-pair analysis was performed on 514 age- and sex-matched pairs with and without T2D. Patients had obesity [body mass index (BMI) 25\u201345 kg\/m\u00b2, aged 20\u201375 years] and participated in a one-year lifestyle intervention program in India. Anthropometric, biochemical markers and medical history were analyzed. Homeostatic model assessment for insulin resistance (HOMA2IR) and beta-cell function (HOMA2%B) was calculated. Significant markers were incorporated into a logistic regression model and temporally validated in an independent time-cohort (n=966). Performance was evaluated through discrimination [receiver operating characteristics area under the curve (ROC-AUC)], calibration, and decision curve analysis. A nomogram was constructed based on the logistic regression model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median age and BMI were 46 (IQR 12) years and 29.7 (IQR 5.5) kg\/m\u00b2. Key markers associated with prevalent T2D were poor beta-cell function (HOMA2%B \u226450; OR\u00a0=\u00a040.9, 95% CI: 24.5\u201368.2), insulin resistance (HOMA2IR \u22652; OR\u00a0=\u00a04.5, 95% CI: 3.0\u20136.7), low HDL-C (OR\u00a0=\u00a02.1, 95% CI: 1.5\u20133.0), elevated hsCRP \u22653 mg\/L (OR\u00a0=\u00a01.9, 95% CI: 1.4\u20132.7), Obesity Class I (BMI 25.0\u201329.9 kg\/m\u00b2; OR\u00a0=\u00a02.1, 95% CI: 1.5\u20132.9), and antihypertensive medication use (OR\u00a0=\u00a01.7, 95% CI: 1.2\u20132.4). Model discrimination was good (AUC 0.860 development, 0.865 validation, both p&amp;lt;0.001). The Hosmer-Lemeshow test showed good model fit (p=0.562). Isotonic-calibrated Models 1 and 2 had Brier scores 0.14 and 0.162, indicating acceptable calibration. Decision curve analysis confirmed net clinical benefit across threshold probabilities 0.10\u20130.85.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified and temporally validated key metabolic and clinical markers associated with prevalent T2D, demonstrating good discrimination (AUC 0.860) in obese Indian individuals. External validation and prospective evaluation are needed before clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcdhc.2026.1809646","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:41:57Z","timestamp":1785908517000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and clinical markers of T2D in obese Indians: an age-sex matched case-control study"],"prefix":"10.3389","volume":"7","author":[{"given":"Anagha","family":"Vyawahare","sequence":"first","affiliation":[{"name":"Research Department, Freedom from Diabetes Research Foundation","place":["Pune, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Research Department, Freedom from Diabetes Research Foundation","place":["Pune, Maharashtra, India"]},{"name":"Department of Management, Freedom from Diabetes Clinic and Research Foundation","place":["Pune, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Kadam","sequence":"additional","affiliation":[{"name":"Research Department, Freedom from Diabetes Research Foundation","place":["Pune, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diptika","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Research Department, Freedom from Diabetes Research Foundation","place":["Pune, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baby","family":"Sharma","sequence":"additional","affiliation":[{"name":"Research Department, Freedom from Diabetes Research Foundation","place":["Pune, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thejas","family":"Kathrikolly","sequence":"additional","affiliation":[{"name":"Research Department, Freedom from Diabetes Research Foundation","place":["Pune, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malhar","family":"Ganla","sequence":"additional","affiliation":[{"name":"Research Department, Freedom from Diabetes Research Foundation","place":["Pune, Maharashtra, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dia Care - Diabetes Hormone Clinic","place":["Ahmedabad, Gujarat, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3558","article-title":"Insulin resistance and beta\u2010cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance","volume":"38","author":"Bonora","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2290","article-title":"Evidence of reduced \u03b2-cell function in Asian Indians with mild dysglycemia","volume":"36","author":"Staimez","year":"2013","journal-title":"Diabetes Care"},{"key":"B3","article-title":"International diabetes federation","volume-title":"IDF Diabetes Atlas. 10th Ed.","author":"Atlas","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: New pathogenetic mechanisms, treatment and the most important complications","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2617","article-title":"Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low\u2010grade inflammation and the development of obesity and diabetes","volume":"31","author":"Bleau","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2020","journal-title":"Front Physiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2018.06.011","article-title":"Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese","volume":"28","author":"Fingeret","year":"2018","journal-title":"Nutrition Metab Cardiovasc Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11892-018-1002-8","article-title":"Diabetes in South Asians: Phenotype, clinical presentation, and natural history","volume":"18","author":"Unnikrishnan","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/ad857b","article-title":"A machine learning classifier-based approach for diabetes mellitus risk prediction","author":"B","year":"2024","journal-title":"BioMed Phys Eng Express"},{"key":"B11","article-title":"A predictive model for early detection of diabetes mellitus using machine learning","volume-title":"Nelson Mandela African Institution of Science and Technology","author":"Furtado","year":"2021"},{"key":"B12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41598-024-84349-5","article-title":"The predictive value of combined insulin resistance and \u03b2-cell secretion in Yemeni school-aged children for type 2 diabetes mellitus","volume":"15","author":"Saeed","year":"2025","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2337\/dc09-1115","article-title":"Insulin resistance, \u03b2-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B15","article-title":"The Asia-Pacific perspective: redefining obesity and its treatment","volume-title":"Sydney: Health Communications Australia","year":"2000"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4274\/Jcrpe.1127","article-title":"A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents","volume":"5","author":"Singh","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3126\/ajms.v13i10.46707","article-title":"Pancreatic beta-cell function and degree of insulin resistance among newly detected type 2 diabetics and their correlation with anthropometric, glucose, and lipid parameters: An observational cross-sectional study","volume":"13","author":"Saha","year":"2022","journal-title":"Asian J Med Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33843","article-title":"Remission and relapse of dyslipidemia after vertical sleeve gastrectomy vs Roux-en-Y gastric bypass in a racially and ethnically diverse population","volume":"5","author":"Coleman","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12872-018-0778-4","article-title":"Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure","volume":"18","author":"Pereira","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"B21","article-title":"Methods in observational epidemiology","volume-title":"United States: New York: Oxford University Press","author":"Kelsey","year":"1986"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7986","article-title":"Estimating the receiver operating characteristic curve in matched case control studies","volume":"38","author":"Xu","year":"2019","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-44296\/v1","article-title":"Development and validation of models to predict cesarean delivery among low-risk nulliparous women at term: A retrospective study in China","volume":"26","author":"Sun","year":"2020"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13410-022-01129-5","volume":"42","author":"Makkar","year":"2022","journal-title":"Int J Diabetes Dev Ctries"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: Standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.10.004","article-title":"Hypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy","volume":"117","author":"Chapman","year":"2008","journal-title":"Pharmacol Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.53","article-title":"Diabetes mellitus and its complications in India","volume":"12","author":"Unnikrishnan","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190528","article-title":"Metabolically healthy obese individuals present similar chronic inflammation level but less insulin-resistance than obese individuals with metabolic syndrome","volume":"12","author":"Iglesias Molli","year":"2017","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06217-1","article-title":"Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population","volume":"67","author":"Donnelly","year":"2024","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41387-018-0042-0","article-title":"Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study","volume":"8","author":"Owusu","year":"2018","journal-title":"Nutr Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S541859","article-title":"Relationship between thyroid hormones and fat distribution in patients with type 2 diabetes mellitus: A cross-sectional study","volume":"18","author":"Yang","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically healthy obesity","volume":"41","author":"Bl\u00fcher","year":"2020","journal-title":"Endocr Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8732360","article-title":"Effect of statins on serum level of hs-CRP and CRP in patients with cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials","volume":"2022","author":"Kandelouei","year":"2022","journal-title":"Mediators Inflammation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-01080","article-title":"HDL-cholesterol, its variability, and the risk of diabetes: A nationwide population-based study","volume":"104","author":"Lee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","article-title":"A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects","volume":"53","author":"Mohan","year":"2005","journal-title":"J Assoc Physicians India"},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.diabres.2005.02.016","article-title":"Derivation and validation of diabetes risk score for urban Asian Indians","volume":"70","author":"Ramachandran","year":"2005","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1809646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:41:59Z","timestamp":1785908519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1809646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":37,"alternative-id":["10.3389\/fcdhc.2026.1809646"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1809646","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1809646"}}